Skip to main content

Table 1 Clinical characteristics of the patients

From: Prognostic significance of urokinase plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in lymph node- and hormone receptor-positive breast cancer

Characteristics

Total (n = 87)

Age at Diagnosis (years)

 

Median (range)

54 (29–74)

Average (SEM)

53 (1.0)

Age categories

 

< 50 years

30 (35%)

≥ 50 years

57 (65%)

Primary surgery

 

Mastectomy

48 (55%)

Lumpectomy

39 (45%)

Histological type

 

Ductal

79 (90%)

Lobular

5 (6%)

Other

3 (4%)

Histological grade

 

SBR I

12 (14%)

SBR II

47 (54%)

SBR III

28 (32%)

Tumor size

 

T1

11 (13%)

T2

63 (72%)

T3

13 (15%)

Nb. positive nodes

 

1–3

55 (63%)

≥ 4

32 (37%)

ER status (IHC)

 

positive

83 (96%)

negative

4 (4%)

PR status (IHC)

 

positive

80 (92%)

negative

7 (8%)

Cancer-provoked death

 

Yes

22 (26%)

No

65 (74%)

Metastasis-relapse

 

Yes

30 (35%)

No

57 (65%)

  1. Abbreviations: ER, estrogen receptor; PR, progesterone receptor; IHC, immunohistochemistry; SBR, Scarff Bloom and Richardson.